T
Teo Seng Capital Bhd
KLSE:TEOSENG
Teo Seng Capital Bhd
KLSE:TEOSENG
Price:
0.865
MYR
-2.81%
Market Cap:
519m
MYR
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Teo Seng Capital Bhd
KLSE:TEOSENG
|
MY |
|
Gattaca PLC
LSE:GATC
|
UK |
|
Jianmin Pharmaceutical Group Co Ltd
SSE:600976
|
CN |
Balance Sheet
Balance Sheet Decomposition
Teo Seng Capital Bhd
Teo Seng Capital Bhd
Balance Sheet Decomposition is not available for
Teo Seng Capital Bhd
Teo Seng Capital Bhd
Balance Sheet
Teo Seng Capital Bhd
Teo Seng Capital Bhd
Currency: MYR
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
18
|
34
|
39
|
30
|
34
|
19
|
30
|
41
|
45
|
49
|
41
|
99
|
127
|
183
|
|
| Cash |
0
|
34
|
39
|
0
|
34
|
19
|
30
|
41
|
45
|
49
|
41
|
99
|
127
|
183
|
|
| Cash Equivalents |
18
|
0
|
0
|
30
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
2
|
3
|
8
|
0
|
0
|
3
|
4
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
36
|
36
|
44
|
49
|
60
|
76
|
74
|
57
|
57
|
72
|
71
|
68
|
67
|
75
|
|
| Accounts Receivables |
28
|
33
|
43
|
42
|
52
|
64
|
57
|
54
|
50
|
67
|
67
|
64
|
63
|
53
|
|
| Other Receivables |
8
|
3
|
1
|
8
|
9
|
12
|
17
|
4
|
6
|
5
|
4
|
4
|
4
|
22
|
|
| Inventory |
42
|
41
|
48
|
0
|
29
|
38
|
96
|
103
|
104
|
59
|
71
|
72
|
75
|
61
|
|
| Other Current Assets |
0
|
1
|
2
|
56
|
50
|
45
|
2
|
3
|
2
|
65
|
57
|
74
|
132
|
152
|
|
| Total Current Assets |
95
|
115
|
135
|
143
|
174
|
179
|
205
|
209
|
208
|
244
|
241
|
313
|
401
|
471
|
|
| PP&E Net |
132
|
143
|
160
|
222
|
294
|
316
|
339
|
354
|
382
|
378
|
379
|
392
|
440
|
505
|
|
| PP&E Gross |
132
|
143
|
160
|
222
|
0
|
0
|
339
|
354
|
382
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
72
|
82
|
91
|
101
|
0
|
0
|
144
|
163
|
183
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
228
N/A
|
258
+13%
|
296
+14%
|
366
+24%
|
468
+28%
|
495
+6%
|
543
+10%
|
563
+4%
|
591
+5%
|
622
+5%
|
620
0%
|
705
+14%
|
846
+20%
|
976
+15%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
15
|
15
|
22
|
23
|
49
|
49
|
3
|
4
|
30
|
63
|
72
|
123
|
140
|
37
|
|
| Accrued Liabilities |
0
|
8
|
15
|
9
|
0
|
0
|
12
|
13
|
10
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
68
|
74
|
64
|
85
|
0
|
0
|
111
|
94
|
110
|
142
|
117
|
47
|
59
|
79
|
|
| Current Portion of Long-Term Debt |
8
|
7
|
6
|
7
|
99
|
127
|
9
|
8
|
19
|
19
|
17
|
17
|
9
|
10
|
|
| Other Current Liabilities |
10
|
8
|
12
|
11
|
1
|
1
|
51
|
42
|
16
|
1
|
1
|
2
|
2
|
44
|
|
| Total Current Liabilities |
101
|
112
|
118
|
135
|
150
|
177
|
186
|
161
|
185
|
225
|
207
|
145
|
162
|
170
|
|
| Long-Term Debt |
9
|
5
|
8
|
24
|
51
|
51
|
55
|
62
|
65
|
57
|
49
|
54
|
31
|
46
|
|
| Deferred Income Tax |
7
|
9
|
11
|
16
|
21
|
18
|
25
|
33
|
33
|
29
|
30
|
29
|
35
|
38
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
116
N/A
|
126
+8%
|
137
+9%
|
174
+27%
|
222
+28%
|
246
+11%
|
265
+8%
|
256
-4%
|
283
+11%
|
311
+10%
|
286
-8%
|
228
-20%
|
228
+0%
|
255
+12%
|
|
| Equity | |||||||||||||||
| Common Stock |
40
|
40
|
40
|
60
|
60
|
60
|
60
|
60
|
60
|
60
|
60
|
60
|
60
|
60
|
|
| Retained Earnings |
59
|
59
|
106
|
127
|
186
|
189
|
218
|
254
|
256
|
260
|
283
|
426
|
565
|
676
|
|
| Additional Paid In Capital |
8
|
8
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Unrealized Security Profit/Loss |
4
|
4
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
8
|
8
|
9
|
6
|
15
|
|
| Other Equity |
0
|
21
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
111
N/A
|
133
+19%
|
158
+19%
|
192
+21%
|
246
+28%
|
249
+1%
|
278
+12%
|
307
+10%
|
308
+0%
|
311
+1%
|
335
+7%
|
477
+43%
|
618
+30%
|
722
+17%
|
|
| Total Liabilities & Equity |
228
N/A
|
258
+13%
|
296
+14%
|
366
+24%
|
468
+28%
|
495
+6%
|
543
+10%
|
563
+4%
|
591
+5%
|
622
+5%
|
620
0%
|
705
+14%
|
846
+20%
|
976
+15%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
609
|
609
|
609
|
609
|
609
|
609
|
609
|
596
|
596
|
596
|
596
|
595
|
593
|
585
|
|
Switch to:
Switch to:
See Also
Discover More
